Allogeneic cell therapy: The treatment of choice for all hematologic malignancies relapsing post BMT [2]

S. Slavin, E. Naparstek, A. Nagler, Y. Kapelushnik, A. Ackerstein, R. Or, H. J. Kolb

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)4011-4013
Number of pages3
JournalBlood
Volume87
Issue number9
DOIs
StatePublished - 1996
Externally publishedYes

Cite this